Mondaq Europe: Food, Drugs, Healthcare, Life Sciences
Schoenherr Attorneys at Law
The amendment aims at alleviating the existing regime for pricing of pharmaceuticals for home treatment of chronic, genetic and/or rare diseases and paid by the National Health Insurance Fund
Schoenherr Attorneys at Law
New legislation regulating e-cigarettes in the Czech Republic entered into force on 1 March 2017, introducing specific safety and quality requirements on e-cigarettes in the country for the first time.
Elkington and Fife LLP
Following a Notice of the European Commission related to certain parts of the EU Biotech Directive (98/44/EC), the EPO has decided to stay all examination and opposition proceedings...
Global Advertising Lawyers Alliance (GALA)
To achieve harmonization with the provisions of EU Regulation no. 1169 of 2011[2], this current legal frame work will have to undergo an extensive review.
Reed Smith (Worldwide)
In France, transparency requirements are regulated by two main sets of laws: "The French Anti-Gift Law" . . .
Reed Smith (Worldwide)
Article body Current Length: 9407 chars Long including spaces Source Preview The relationship between the life sciences industry and health-care practitioners is being reshaped in France through regulatory developments under both the French Anti-Gift Law and the French Sunshine Act.
Jones Day
Titanium dioxide (E 171) is a food additive that is widely used in foods and confectionery as a whitening agent.
Arthur Cox
The new Medical Device Regulations, whose final drafts were published by the Council of the European Union last week, will result in an additional layer of review of technical documentation...
Bedell Cristin
A new law has been approved by the States of Jersey which will radically change the way the Island responds to mental health issues.
Dentons
We would like to present the overview of the most important legislation changes in life sciences for 2016.
Bar & Karrer
In its decision of 14 December 2015, the Swiss Federal Supreme Court had confirmed that the practice of the Federal Office of Public Health (FOPH) which, in the course of the regular triennial review, determines the prices of drugs...
Bar & Karrer
Das Bundesgericht hatte mit Urteil vom 14. Dezember 2015 bestätigt, dass die Praxis des Bundesamts für Gesundheit (BAG), die Preise von Arzneimitteln der Spezialitätenliste (SL) bei der ordentlichen Dreijahresüberprüfung grundsätzlich nur im Vergleich mit den Auslandpreisen zu überprüfen, gegen das Krankenversicherungsgesetz (KVG) verstösst.
Erdem & Erdem Law
Medicine has been defined by the World Health Organization as "products that are used to change or analyze physiological and pathological circumstances to the benefit of the user."
ELIG, Attorneys-at-Law
In 2014, the Turkish Medicine and Medical Device Institution's ("Institution") New Year's resolution list included two remarkable items: (i) ensuring people's access to safe human medicinal products, and (ii) battling the grey economy.
Moroğlu Arseven
Turkey's Tobacco and Alcohol Market Regulatory Board has increased compliance and service fees by 3.83% for 2017.
Clyde & Co
A GP defended at trial by Richard Manstoff of the Clyde's Healthcare team was this month found not to have breached any duty of care owed to a patient who presented with a swelling ...
Deloitte
There is increasing evidence that a wholesale transformation of health and social care delivery is urgently needed.
Deloitte
This week our colleague Sriram Prakash, Deloitte's global lead for mergers and acquisitions (M&A) insight, published the cross industry M&A Index Outlook for 2017.
Arnold & Porter Kaye Scholer LLP
2017 has started with a bang on the data protection front. There have been several developments these past few months, ranging from updates on the new EU General Data Protection Regulation ("GDPR"), coming into force in May 2018, to the establishment of a Swiss-EU Privacy Shield.
Deloitte
Most healthcare systems are battling with the challenge of delivering both better patient outcomes – in an environment of increasing prevalence of diseases – while managing escalating costs.
Latest Video
Most Popular Recent Articles
Mamo TCV Advocates
Without doubt Malta offers significant opportunities for the generics drugs Industry and the evidence for this lies in the pharmaceutical patenting history of the country and in its legislative framework.
Bar & Karrer
In its decision of 14 December 2015, the Swiss Federal Supreme Court had confirmed that the practice of the Federal Office of Public Health (FOPH) which, in the course of the regular triennial review, determines the prices of drugs...
Deloitte
This highlights the key challenges, trends and opportunities facing the global life science industry in 2017 and beyond and what is currently being done or could be done to respond to these challenges.
Erdem & Erdem Law
Medicine has been defined by the World Health Organization as "products that are used to change or analyze physiological and pathological circumstances to the benefit of the user."
Elkington and Fife LLP
Following a Notice of the European Commission related to certain parts of the EU Biotech Directive (98/44/EC), the EPO has decided to stay all examination and opposition proceedings...
Schoenherr Attorneys at Law
2016 has seen a surprising level of deal activity in the (private) Austrian hospital sector: in Vienna, PremiQaMed, a 100 % subsidiary of UNIQA insurance group, acquired a 75 % stake in the renowned private hospital "Goldenes Kreuz", and the hospitals Hartmannspital and St. Elisabeth announced a merger to form the new "Franziskus" hospital.
Deloitte
In January, Deloitte published its 2017 Global healthcare sector outlook, which confirms that the challenges of providing and funding health care around the globe have remained fairly persistent...
Deloitte
Most healthcare systems are battling with the challenge of delivering both better patient outcomes – in an environment of increasing prevalence of diseases – while managing escalating costs.
Schoenherr Attorneys at Law
The amendment aims at alleviating the existing regime for pricing of pharmaceuticals for home treatment of chronic, genetic and/or rare diseases and paid by the National Health Insurance Fund
Clyde & Co
The Department of Health has recently launched a consultation into fixed recoverable costs in clinical negligence claims.
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter